PBMWW Psyence Biomedical Ltd. - Warrant

NASDAQ ·
$0.03
Price · Aug 19, 2026

PBMWW Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$0.03
Market Cap
P/E (TTM)
EPS (TTM)
Revenue (TTM)
Div Yield
ROE
Debt/Equity
52W Range
$0 – $0

PBMWW Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
EPS
Free Cash Flow
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
PBMWW
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
PBMWW
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
PBMWW
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
PBMWW
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
PBMWW
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
PBMWW
Peer Median

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 20 filers · $129K total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
1 (0 vs prior Q) 2 (-1 vs prior Q) 0 (-1 vs prior Q) 4 (+3 vs prior Q) -119K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Harraden Circle Investments, LLC $27,921 1,149,000 21.64% Shares
Polar Asset Management Partners Inc. $16,639 733,000 12.90% Shares
MMCAP International Inc. SPC $14,580 600,000 11.30% Shares
TORONTO DOMINION BANK $12,072 503,012 9.36% Shares
Calamos Advisors LLC $10,500 500,000 8.14% Shares
Saba Capital Management, L.P. $7,238 297,847 5.61% Shares
Clear Street Group Inc. $6,250 257,202 4.84% Shares
GOLDMAN SACHS GROUP INC $4,863 200,117 3.77% Shares
LMR Partners LLP $4,860 200,000 3.77% Shares
D. E. Shaw & Co., Inc. $3,682 175,352 2.85% Shares
CLEAR STREET LLC $3,663 180,466 2.84% Shares
TENOR CAPITAL MANAGEMENT Co., L.P. $3,645 150,000 2.83% Shares
WOLVERINE ASSET MANAGEMENT LLC $3,575 147,101 2.77% Shares
MILLENNIUM MANAGEMENT LLC $2,624 108,000 2.03% Call option
ARISTEIA CAPITAL, L.L.C. $2,618 115,319 2.03% Shares
Clear Street Derivatives LLC $2,220 109,356 1.72% Shares
LPL Financial LLC $1,193 49,095 0.92% Shares
Parallel Advisors, LLC $668 27,500 0.52% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $212 10,119 0.16% Shares
Mint Tower Capital Management B.V. $1 50,000 0.00% Shares

Activists & 5%+ owners 2 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Psyence Labs Ltd. June 3, 2026 30.05% Initial filing Passive investment SEC
KAOS Capital Ltd., Adam Arviv Dec. 10, 2025 16.77% Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.